Clinical efficacy studies of haloprogin, a new topical antimicrobial agent.
D000480:Alkynes / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003881:Dermatomycoses / Q000188:drug therapy*; D006801:Humans; D007455:Iodine / Q000627:therapeutic use; D010636:Phenols / Q000627:therapeutic use*; D010919:Placebos; D011188:Potassium / Q000032:analysis; D012867:Skin / Q000032:analysis; D014006:Tinea Capitis / Q000188:drug therapy; D014008:Tinea Pedis / Q000188:drug therapy; D014010:Tinea Versicolor / Q000188:drug therapy; D014047:Tolnaftate / Q000627:therapeutic use; D014249:Trichophyton
D000480:Alkynes; D000891:Anti-Infective Agents, Local; D000935:Antifungal Agents; D010636:Phenols; D010919:Placebos; D014047:Tolnaftate; D007455:Iodine; D011188:Potassium